Open AccessEffect of Endocrine Therapy on Quality of Life and Cognitive Functions in Patients with Breast Cancer
Author(s) -
Saadettin Kılıçkap,
Mutlu Hayran,
B. Çakır,
Nesrin Çilingiroğlu,
Mustafa Erman,
Guldal Buyukdamgaci,
Yavuz Özışık
Publication year - 2013
Publication title -
breast care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.767
H-Index - 30
eISSN - 1661-3805
pISSN - 1661-3791
DOI - 10.1159/000350780
Subject(s) - medicine , tamoxifen , breast cancer , quality of life (healthcare) , oncology , cancer , cognition , endocrine system , gynecology , hormone , psychiatry , nursing
The use of endocrine therapy (ET) in postmenopausal breast cancer patients may affect their cognitive status. This study aims to assess the effects of tamoxifen and aromatase inhibitors (Als) on quality of life (QoL) and cognitive functions in breast cancer patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom